CWGCX
Price
$79.95
Change
-$0.06 (-0.07%)
Updated
Jul 2 closing price
Net Assets
159.53B
GCEYX
Price
$18.41
Change
+$0.17 (+0.93%)
Updated
Jul 2 closing price
Net Assets
1.42B
Interact to see
Advertisement

CWGCX vs GCEYX

CWGCX vs GCEYX Comparison Chart in %
View a ticker or compare two or three
VS
CWGCX vs. GCEYX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and GCEYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 160B vs. GCEYX (1.42B). GCEYX pays higher dividends than CWGCX: GCEYX (0.82) vs CWGCX (0.71). CWGCX was incepted earlier than GCEYX: CWGCX (25 years) vs GCEYX (12 years). CWGCX (1.48) is less costly to investors than GCEYX (0.78). GCEYX is a more actively managed with annual turnover of: 67.00 vs. CWGCX (44.00). GCEYX has a lower initial minimum investment than CWGCX: GCEYX (0) vs CWGCX (250). CWGCX annual gain was more profitable for investors over the last year : 14.79 vs. GCEYX (-2.64). CWGCX return over 5 years is better than : 28.50 vs. GCEYX (7.62).
CWGCXGCEYXCWGCX / GCEYX
Total Expense Ratio1.480.78190%
Annual Report Gross Expense Ratio1.480.78190%
Fund Existence25 years12 years-
Gain YTD13.8054.841285%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets160B1.42B11,276%
Annual Yield % from dividends0.710.8287%
Returns for 1 year14.79-2.64-561%
Returns for 3 years44.9326.27171%
Returns for 5 years28.507.62374%
Returns for 10 years92.93100.4693%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX201.095.09
+2.60%
Franklin Biotechnology Discovery A
CVCFX17.350.19
+1.11%
Victory Pioneer Disciplined Value C
PMJPX13.73-0.07
-0.51%
PIMCO RAE US Small I-2
FMAGX15.42-0.21
-1.34%
Fidelity Magellan
QCGDX16.71-0.26
-1.53%
Quantified Common Ground Investor